โ† All deals

EndoSure, Inc.

Other Health CareHealthTechDiagnostic EquipmentFemTech
๐Ÿ“ Sparks Glencoe, MD, United Statesโ€ข Founded 2022
StreetZero Signal 62
Be the first to signal interest

About EndoSure, Inc.

EndoSure, Inc. is the developer of a non-invasive diagnostic test for endometriosis detection. The company utilizes clinical testing and rapid-result technology to provide half-hour assessments and post-treatment monitoring for physicians and patients. It operates in the diagnostic equipment and medical laboratories sector with a focus on FemTech and HealthTech.

LATEST FUNDINGPrivate Placement
$1.3M
Announced 2026-11-19
TOTAL RAISED$150K
๐Ÿ”’

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for EndoSure, Inc..

Free plan includes 3 full deal profiles every month.

EMPLOYEESโ€”
FOUNDED2022
HQSparks Glencoe, MD, United States
Industry
Other Health Care
Tags
HealthTechDiagnostic EquipmentFemTechB2B

Investors

Not disclosed in the source filing. Form D filings do not list investors โ€” StreetZero surfaces them from news where available.

Key highlights

  • Developed non-invasive 30-minute endometriosis diagnostic test with instant results
  • Received NIH RADx Tech ACT ENDO Challenge award via partner 3CPM
  • Angel-backed with headquarters in Sparks Glencoe, MD
  • Focuses on women's health diagnostics gap

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.

Sign in to view the filing Create free account